Other Infections
CROI 2015: International Ebola Response Too Little, Too Late [VIDEO]
- Details
- Category: Emerging Diseases
- Published on Monday, 23 February 2015 00:00
- Written by Gregory Fowler
An HIV clinic in hard-hit Guinea saw a 50% drop in people coming to the facility in the midst of the Ebola epidemic, and the global response has been inadequate, researchers said at the opening press conference of the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) taking place this week in Seattle. According to another report, the antiviral drug favipiravir (Avigan) appeared to help some patients with less-severe Ebola virus disease, but more effective therapies are still needed.
Affordable Care Act Open Enrollment Deadline Coming Up February 15
- Details
- Category: Health Care & Insurance Reform
- Published on Wednesday, 11 February 2015 00:00
- Written by HIVandHepatitis.com
Sunday, February 15, is the final deadline to enroll in Affordable Care Act ("Obamacare") health plans during the annual open enrollment period. Finding the right plan can be a challenge for people with HIV or hepatitis C and those who want coverage for pre-exposure prophylaxis (PrEP). It is important to balance monthly premium costs, copays, and deductibles to best meet individual needs.
14. Delegates Killed in Plane Crash Going to International AIDS Conference
- Details
- Category: Miscellaneous Health News
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
The 2014 International AIDS Conference in Melbourne got off to a somber start in July after several HIV researchers and advocates en route to the meeting were killed on Malaysian Airlines flight MH17 from Amsterdam to Kuala Lumpur, which crashed after being hit by a missile near the Russia-Ukraine border.
Ezetimibe Did Not Reduce Liver Fat in NASH Trial, New Therapies Under Study
- Details
- Category: Steatosis/NAFLD/NASH
- Published on Thursday, 29 January 2015 00:00
- Written by HIVandHepatitis.com
Ezetimibe (Zetia) did not perform significantly better than placebo in reducing liver fat among people with non-alcoholic steatohepatitis (NASH), according to a report in the December 6 edition of Hepatology. In related news, the FDA has designated Tobira's cenicriviroc -- also active against HIV -- as a fast-track therapy for NASH and Gilead Sciences announced a partnership to enter the NASH arena.
Latest CDC Sexually Transmitted Disease Report Shows Gonorrhea Stable, Syphilis Rising
- Details
- Category: Other STDs
- Published on Wednesday, 17 December 2014 00:00
- Written by CDC
The number of cases of chlamydia declined slightly from 2012 to 2013, while cases of gonorrhea remained nearly stable and syphilis increased by 10%, according the latest Centers for Disease Control and Prevention (CDC) annual STD surveillance report. These broad trends, however, mask some notable differences between population groups, including high STD rates among gay men.
12. New Human Papillomavirus Vaccine Protects Against 9 Strains
- Details
- Category: Human Papillomavirus (HPV)
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
In December the U.S. Food and Drug Administration (FDA) approved a new "9-valent" human papillomavirus (HPV) vaccine from Merck that protects against more cancer-causing strains. The new Gardasil 9 vaccine is expected to prevent about 90% of cervical, anal, and genital cancers. The vaccine is approved for young women ages 9-26 and young men ages 9-15.
WHO Recommends 2-Dose Vaccine, HPV Screening for Cervical Cancer Prevention
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 09 December 2014 00:00
- Written by WHO
The World Health Organization (WHO) last week released new guidance for preventing and controlling cervical cancer, which causes more than 270,000 deaths annually worldwide. The guidelines call for girls to receive 2 rather than 3 doses of the human papillomavirus (HPV) vaccine and for women to be screened using less frequent HPV tests rather than Pap smears.
13. Ebola Death Toll Tops 8000, Stigma Recalls Early AIDS Epidemic
- Details
- Category: Emerging Diseases
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
Outside the HIV and hepatitis fields, the major health topic in 2014 was the emergence of an Ebola virus outbreak in West Africa. While only a small number of cases have been seen in the U.S. and Europe, the resulting stigma and panic reminded many of the early AIDS epidemic.
FDA Approves New Vaccine Effective Against 9 Types of Human Papillomavirus
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 09 December 2014 00:00
- Written by WHO
The U.S. Food and Drug Administration this week approved a new "9-valent" human papillomavirus (HPV) vaccine from Merck that protects against infection with more high-risk or cancer-causing strains. The new Gardasil 9 vaccine is expected to prevent about 90% of cervical, anal, and genital cancers. The vaccine is approved for young women ages 9-26 and young men ages 9-15.
More Articles...
- Hospitalizations Due to Hepatitis A Declining in the U.S., CDC Study Finds
- Health Officials, Infectious Disease Experts, AIDS Activists Oppose Ebola Quarantine
- New WHO Report Finds Tuberculosis More Common than Previously Estimated
- IDWeek 2014: Syphilis Cases Increase Among Men with HIV Despite Risk Reduction Counseling
- Coffee Linked to Reduced Liver Inflammation, Lower Liver Cancer Risk
Web Design and Development by